Why a prostate biopsy is not a one-line price
A South Korean prostate-biopsy quote can contain much more than the tissue-sampling line. Ultrasound or MRI-fusion guidance, anesthesia or sedation, recovery, antibiotics, specimen handling, pathology interpretation, consultation, and admission may appear as separate items. Two providers can both write “prostate biopsy” while quoting different methods, care settings, core counts, and pathology scopes.
This calculator does not publish or invent a Korean national-average prostate biopsy price. Every price starts at zero. Enter the gross covered charge and copay rate confirmed by the billing office, the provider-disclosed non-covered or full-self-pay biopsy fee, and each already-calculated patient-paid add-on. The calculator then shows one episode and a repeat-inclusive planning budget.
Insurance generation is recorded only to prepare the insurer call. It never sets an automatic payout percentage. Subtract only the per-episode amount that the insurer confirmed for the exact procedure, benefit classification, and outpatient or admission setting.
What this calculator can answer
- Whether Provider A and Provider B quote the same method, setting, core count, pathology, and included-item scope
- Whether covered care, non-covered biopsy cost, imaging, anesthesia, pathology, medicine, or admission may be missing
- The medical and household cost for one episode after an insurer-confirmed payment
- A simple total for the initial biopsy plus zero, one, or two additional repeat episodes
Align transrectal, transperineal, and MRI-fusion quote scope
The method selector does not decide a clinical path or assign a price. It records the path already stated by the clinician so that two quotes can be compared on the same basis. An MRI-fusion targeted biopsy can still differ by physical access route, whether prior MRI is included, whether systematic cores are also taken, and how pathology is billed.
Quote-scope checks for three prostate-biopsy methods| Method label | Ask the provider to confirm | Calculator treatment |
|---|
| Transrectal systematic biopsy | Ultrasound guidance, anesthesia, antibiotics, core count, and pathology inclusion | Adds only provider-confirmed amounts |
| Transperineal systematic biopsy | Outpatient or admission setting, anesthesia, recovery, core count, and pathology scope | Checks that setting and inclusions align |
| MRI-fusion targeted biopsy | Prior MRI, same-day fusion guidance, systematic plus targeted cores, anesthesia, and pathology | Warns when imaging cost and scope remain unconfirmed |
Core count is not a per-core price multiplier
Core count is a pathology-scope check. The calculator does not multiply it by a fabricated unit price. Enter the patient-paid specimen and pathology amount stated by the provider. If the two core counts differ, the calculator keeps showing the arithmetic difference but marks the comparison as not like-for-like.
Separate the quote into three cost layers
1. Gross covered charge
This is the covered assessment base before the patient share. Apply the exact rate confirmed by the billing office only once.
2. Non-covered biopsy fee
Use the disclosed non-covered or full-self-pay patient amount for tissue sampling. Do not duplicate a line already inside the covered gross amount.
3. Patient-paid add-ons
Enter imaging, anesthesia, pathology, medicine, consultation, and admission as patient amounts already stated by the provider. Do not apply the copay rate again.
A common double-counting error is entering a gross covered pathology line and then entering its already-calculated patient share again. The opposite error is copying only the biopsy procedure line while omitting pathology or recovery-room charges. Ask the provider whether each number is a pre-copay gross amount or a final patient-paid amount, and map each detailed-statement line to one input field.
The 2026 Korean benefit, non-covered, and indemnity-insurance boundary
National Health Insurance Act
Article 41 of the National Health Insurance Act places consultations and tests within the medical-care benefit framework while allowing designated non-covered exclusions. Article 44 requires a beneficiary to pay the patient share set under the Presidential Decree. The current act verified on August 20, 2026 is statute ID 001971, MST 276651, effective January 2, 2026.
Patient share and detailed benefit rules
Enforcement Decree Article 19 points patient-share rates and amounts to Appendix 2. The current decree is ID 002813, MST 283469, effective February 19, 2026. Medical Care Benefit Rules Articles 5 and 9 place detailed coverage standards in notices and non-covered categories in Appendix 2. The current rules are ID 006697, MST 285513, effective April 15, 2026.
These provisions do not create one universal prostate-biopsy copay. Provider level, outpatient or admission setting, actual services, materials, pathology scope, and claim review can matter. Use the gross charge and exact percentage confirmed for this episode instead of guessing from the test name.
Non-covered price disclosure
Medical Service Act Article 45 requires providers to disclose non-covered fees so patients or caregivers can understand them and prohibits charging above the disclosed amount. Article 45-2 establishes reporting and public analysis of non-covered item names, standards, amounts, and treatment details. The current act is ID 001788, MST 285327, effective April 7, 2026.
A disclosed number can still cover a different package of imaging, anesthesia, specimen handling, or pathology. Pair the disclosure with the itemized statement and the exact EDI code rather than treating a portal number as a complete episode price.
Fifth-generation indemnity insurance
South Korea launched fifth-generation indemnity medical insurance on May 6, 2026. Benefit-outpatient cost sharing and non-covered riders changed, but generation alone still cannot adjudicate this biopsy. Product terms, riders, exclusions, limits, care setting, and the actual benefit classification remain relevant. The calculator therefore accepts only an insurer-confirmed planning payout and caps it at the episode medical cost.
Formula and result interpretation
One-episode calculation
- Covered patient share = gross covered charge × confirmed copay rate
- Medical add-ons = imaging + anesthesia + pathology + medicine + consultation/admission + other medical cost
- Medical cost before payout = covered patient share + non-covered biopsy fee + medical add-ons
- Applied payout = the smaller of medical cost and insurer-confirmed payout
- Household cost per episode = medical cost − applied payout + transport + companion time or replacement care
The arithmetic NHI share estimate is gross covered charge minus the calculated covered patient share. It is a budget breakdown, not an NHIS adjudication, claim approval, or final provider settlement. Transport and companion costs are not assumed to be indemnity-insurance benefits.
Repeat-inclusive plan
Total episode count equals one initial episode plus zero to two entered repeats. The plan multiplies the current one-episode amounts by that count. This is a cash reserve scenario, not a recommendation or prediction that a repeat will occur. Recalculate with a new quote if a later episode uses a different method, core count, pathology scope, setting, or insurance classification.
Worked Provider A and Provider B example
Assume both providers quote a transperineal systematic outpatient biopsy with 12 cores, one additional repeat, and all five confirmation checks completed. The following numbers are a virtual calculation example, not Korean market averages.
Virtual Provider A and Provider B prostate-biopsy cost example| Item | Provider A | Provider B |
|---|
| Gross covered charge | KRW 600,000 | KRW 400,000 |
| Confirmed copay rate | 20% | 20% |
| Non-covered biopsy fee | KRW 100,000 | KRW 350,000 |
| Imaging, anesthesia, pathology, medicine, and consultation | KRW 380,000 | KRW 470,000 |
| Insurer-confirmed payout | KRW 200,000 | KRW 250,000 |
| Transport and companion cost | KRW 50,000 | KRW 30,000 |
| Household cost for one episode | KRW 450,000 | KRW 680,000 |
| Initial episode plus one repeat | KRW 900,000 | KRW 1,360,000 |
Provider A produces a covered patient share of KRW 120,000 and an arithmetic NHI-share estimate of KRW 480,000. Medical cost before the private payout is KRW 600,000. After the confirmed KRW 200,000 payout and KRW 50,000 indirect cost, the household needs KRW 450,000 for one episode and KRW 900,000 for two episodes.
Provider B produces KRW 680,000 per episode and KRW 1,360,000 for the same two-episode assumption. The per-episode difference is KRW 230,000 and the plan difference is KRW 460,000. These arithmetic differences do not establish that the lower quote is medically appropriate or a better provider.
Step-by-step use
- Match method and care setting. Select the clinician-stated transrectal, transperineal, or MRI-fusion path and the provider-confirmed outpatient or admission setting.
- Enter core count and repeat assumption. Use the planned cores as a scope check and choose only the additional repeat count you want in the cash reserve.
- Confirm gross covered charge and copay rate. Do not guess from provider type or apply a cancer special-case rate merely because cancer is suspected.
- Copy non-covered and patient-paid add-ons line by line. Confirm whether imaging, anesthesia, pathology, antibiotics, consultation, and admission are included or separate.
- Add only a confirmed insurance amount. Give the insurer the procedure name, classification, and care setting rather than relying on generation alone.
- Complete all five scope checks. The comparison becomes like-for-like only after procedure code, cores, anesthesia, pathology, and all inclusions are confirmed for both quotes.
Questions to ask before booking
Provider billing office and biopsy unit
- What is the exact Korean procedure name and EDI code on the detailed statement?
- Does this quote cover transrectal, transperineal, or MRI-fusion scope?
- Is the episode outpatient, day admission, or inpatient?
- How many cores are planned, and is pathology bundled or separate?
- Are imaging guidance, anesthesia, recovery, antibiotics, consultation, admission, and room charges included?
- What gross covered amount and patient-share rate apply to this episode?
- Which additional charges can appear after the current estimate?
Indemnity insurer
- Is this exact procedure and benefit classification reviewable under the policy?
- Do outpatient and admission limits, deductibles, or riders differ?
- Are imaging guidance, anesthesia, pathology, and medicine part of the same claim event?
- What per-episode amount is reasonable for a planning estimate after policy review?
- Which receipt, detailed statement, and clinical documents are required?
- Would a later repeat be a separate claim event, limit, or deductible?
Practical scenarios and limits
Comparing a transrectal and a transperineal path
These are different clinician-proposed paths, so cost alone should not select between them. Enter each in one quote column to expose missing items and household cash needs, then use the result to organize questions for the medical consultation.
An MRI-fusion quote looks much higher
Confirm whether prior MRI has already been completed, whether the quote includes only same-day fusion guidance, and whether systematic cores are taken with targeted cores. A scope difference can explain a price difference without making either quote wrong.
Pathology is not visible on the first quote
Ask whether specimen processing and interpretation are bundled into tissue sampling or billed separately. Until the pathology check is complete, the calculator will not mark the provider comparison as aligned.
Building a reserve for one possible repeat
Enter one additional repeat to double the current episode budget. This does not predict that a repeat is needed. Replace the assumption with a new quote when a later method, pathology scope, or insurance status is known.
Medical decision boundary
This page does not interpret PSA or MRI findings, predict cancer, decide whether a biopsy is needed, select an access route, prescribe cores or anesthesia, interpret pathology, rank providers, or recommend treatment. If there is a clinical concern before or after a procedure, follow the provider’s instructions and seek medical care rather than relying on a cost result.
Frequently asked questions
Does this show an average prostate-biopsy price in Korea?
No. Every amount starts at zero because method, setting, cores, guidance, anesthesia, pathology, and quote scope can differ. Enter the actual provider and billing-office amounts.
Should I leave the default 20% copay?
The editable 20% value demonstrates the interface; it is not a personal coverage determination. Replace it with the exact rate confirmed for this episode.
Can I apply a cancer special-case rate because cancer is suspected?
The calculator never applies a special-case rate from suspicion or a biopsy recommendation. Enter only the rate that the provider confirmed for the current covered lines.
Does choosing an insurance generation calculate a payout?
No. Generation is a call-note field. Enter only a payout confirmed after the insurer reviews the exact procedure, classification, and care setting.
What if the confirmed payout is larger than medical cost?
The applied payout is capped at medical cost and a warning is shown. Transport and companion time are not treated as indemnity-insurance benefits.
Is the repeat-biopsy budget a prediction?
No. It repeats the current amount as a cash-reserve scenario. Recalculate when the later method, cores, pathology scope, and insurance terms are known.
Official sources and update boundary
- National Law Information Center: National Health Insurance Act ID 001971, MST 276651, Articles 41 and 44, effective January 2, 2026
- National Law Information Center: National Health Insurance Act Enforcement Decree ID 002813, MST 283469, Article 19, effective February 19, 2026
- National Law Information Center: Medical Care Benefit Rules ID 006697, MST 285513, Articles 5 and 9, effective April 15, 2026
- National Law Information Center: Medical Service Act ID 001788, MST 285327, Articles 45 and 45-2, effective April 7, 2026
- Health Insurance Review and Assessment Service guidance for non-covered fee information and item-name or EDI-code review
- Financial Services Commission release for fifth-generation indemnity medical insurance launched May 6, 2026
Official sources were last checked on August 20, 2026. Recheck the current law, notices, provider disclosures, detailed statement, and policy terms when booking. A legal or product update does not turn this calculator into a benefit, insurer, or medical decision.
Align both quote scopes before booking
Confirm the procedure code, core count, anesthesia, pathology, and every included item, then enter the actual patient amounts. Save the result as a checklist for the provider and insurer so that missing charges are easier to identify before the appointment.